sorafenib
Sorafenib is a drug used to treat Hepatocellular Carcinoma, Acute Myeloid Leukemia, Liver Cancer, and other conditions. Sorafenib is being actively studied in 56 studies and prior, has been studied in 171.
| Top Sponsors | Top Sites | Top Investigators |
|---|---|---|
| M.D. Anderson Cancer Center | Samsung Medical Center | Shi Ming |
| Sun Yat-sen University | Cancer Center Sun Yat-sen University | Qifa Liu |
| SCRI Development Innovations, LLC | University of Texas MD Anderson Cancer Center | Guohong Han |
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
L
Terminated
- Carcinoma, Hepatocellular
- Proton Beam Radiotherapy
- Sorafenib
- Loma Linda, CaliforniaLoma Linda University Medical Center
2021-09-21
Sep 21, 2021P
Completed
- HepatoCellular Carcinoma
- Portal Vein Thrombosis
- HAIC
- Sorafenib
- Beijing, Beijing, ChinaPeking University Cancer Hospital
2021-10-08
Oct 8, 2021T
Active, not recruiting
- Differentiated Thyroid Cancer
- Everolimus
- Sorafenib
- Philadelphia, PennsylvaniaHospital of the University of Pennsylvania
2021-10-18
Oct 18, 2021M
Recruiting
- Hepatocellular Carcinoma
- +2 more
- MTL-CEBPA
- Sorafenib
- Duarte, California
- +1 more
2022-02-20
Feb 20, 2022B
Efficacy and Safety of Sorafenib in Previously Treated Advanced Hepatocellular Carcinoma: SOPT Study
Not yet recruiting
- Advanced Hepatocellular Carcinoma
- Sorafenib
- (no location specified)
2021-11-02
Nov 2, 2021Y
Completed
- Hepatocellular Carcinoma
- Hepatoma
- sorafenib
- LC Bead-TACE
- Baltimore, MarylandThe Johns Hopkins Hospital
2021-10-15
Oct 15, 2021N
Completed
- Brain Tumor
- +2 more
- everolimus
- sorafenib
- Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
2022-01-07
Jan 7, 2022N
Completed
- Acute Myeloid Leukemia With FLT3/ITD Mutation
- Bone Marrow Transplantation
- +2 more
- Baltimore, Maryland
- +1 more
2021-05-27
May 27, 2021M
Completed
- Advanced Adult Hepatocellular Carcinoma
- +10 more
- Laboratory Biomarker Analysis
- +4 more
- Houston, TexasM D Anderson Cancer Center
2021-12-01
Dec 1, 2021W
Recruiting
- Hepatocellular Cancer
- hepatic resection
- Sorafenib
- Shanghai, ChinaEastern Hepatobiliary Surgery Hospital
2021-04-08
Apr 8, 2021H
Recruiting
- Pancreas Cancer
- Vemurafenib
- Sorafenib
- Scottsdale, ArizonaHonorHealth Research Institute
2021-10-28
Oct 28, 2021S
Completed
- Hepatocellular Carcinoma
- HAIC
- Sorafenib
- Guangzhou, Guangdong, ChinaCancer Center Sun Yat-sen University
2021-11-16
Nov 16, 2021H
Completed
- Hepatocellular Cancer
- Liver Cancer
- Trametinib
- Sorafenib
- Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
2021-06-09
Jun 9, 2021S
E
Completed
- Hepatocellular Carcinoma
- Sorafenib
- Tucson, Arizona
- +23 more
2021-04-16
Apr 16, 2021C
Recruiting
- Radiotherapy
- +3 more
- Radiotherapy plus Toripalimab
- Sorafenib
- Beijing, Beijing, ChinaBo Chen
2021-03-06
Mar 6, 2021B
Enrolling by invitation
- Carcinoma, Hepatocellular
- Portal Vein Tumor Thrombus
- Lenvatinib Pill
- +2 more
- Beijing, Beijing, ChinaBeijing Ditan Hospital, Capital Medical University
2021-07-19
Jul 19, 2021T
Active, not recruiting
- Hepatocellular Carcinoma
- Advanced Cancer
- Sorafenib
- CVM-1118
- Charleston, South Carolina
- +2 more
2022-01-25
Jan 25, 2022S
Recruiting
- Hepatocellular Carcinoma
- Toripalimab
- Sorafenib
- Shanghai, ChinaZhongshan Hospital
2021-06-14
Jun 14, 2021I
Recruiting
- Hepatocellular Carcinoma
- IBI310
- +2 more
- Shanghai, Shanghai, ChinaFudan Universtiy Zhongshan Hospital
2021-11-26
Nov 26, 2021F
Active, not recruiting
- Hepatocellular Carcinoma
- Recombinant Human Adenovirus Type 5 injection
- Sorafenib
- Xi'an, Shaanxi, China
- +3 more
2022-01-25
Jan 25, 2022U
Completed
- Hepatocellular Carcinoma
- Sorafenib
- Toronto, Ontario, CanadaUniversity Health Network
2021-10-04
Oct 4, 2021M
Active, not recruiting
- Hepatocellular Carcinoma
- Sorafenib
- Doxorubicin
- Basking Ridge, New Jersey
- +5 more
2021-05-04
May 4, 2021M
Completed
- Breast Cancer
- Brain Metastases
- Whole Brain Radiotherapy (WBRT)
- Sorafenib
- Basking Ridge, New Jersey
- +5 more
2022-03-04
Mar 4, 2022S
Completed
- Advanced Solid Tumors
- Hepatocellular Carcinoma
- BBI503
- Sorafenib
- Chiba, Etc., Japan5 Sites
2021-03-23
Mar 23, 2021